Benralizumab used to treat near-fatal asthma

Benralizumab has been used to treat an acute asthma attack in a patient with a serious adverse reaction to steroids, respiratory physicians in the UK report. The anti-IL5ra monoclonal antibody is licensed in the UK for the prevention of asthma attacks only. The team of doctors from the Nuffield Department of Clinical Medicine, Oxford, detailed ...

Already a member?

Login to keep reading.

© 2021 the limbic